Maricann Group Inc Separating Itself From The Junior Cannabis Pack

Maricann Group Inc (CNSX:MARI) (OTCMKTS:MRRCF) (FRA:75M) continues to display relative out-performance versus its small cap peer group today. The stock is currently up $0.09 to $1.69/share (↑5.63%), almost reaching the $1.75 per share warrant exercise price which still has two years before the closing date expires. It’s a fantastic beginning for those who bought into the private placement, which closed on August 10th.

For those following the sector, this recent burst of strength shouldn’t come as a surprise.

While Maricann Group was battling negative sentiment stemming from lingering skepticism pertaining to events surrounding the termination of a $70 million bought deal financing and subsequent insider investigation, all they’ve been doing in executing.

In late June, Maricann Group made a quantum leap towards leaving the past behind when it inked a 550,000 gram (minimum) supply deal with provincial crown corporation Manitoba Liquor & Lotteries (MBLL). Not only was the company’s first offtake agreement a PR and optics shot-in-the-arm, we speculated that it might prelude a much-needed financing on Bay St. Sure enough, that’s exactly what happened—no doubt fortified by larger subsequent supply agreements in both Alberta and British Columbia.

Post-financing, the company is going on the offensive in order to raise its asset awareness further, which many consider undervalued.

On Monday, Maricann announced the official launch of MariPlant, the Company’s European nutraceutical product line. MariPlant products will be available for sale in Germany, with strategic expansion planned throughout the European Union. The company is only one of a handful of Canadian LPs with EU-GMP certification, and subsequent ability to wholesale product throughout the continent. Obviously, that’s a very valuable asset on its own.

A couple days later, the company announced that it had successfully exported dry cannabis flowers to Germany from its EU-GMP certified facility in Langton, ON Canada. While this development was already expected by the market, it nonetheless provided crystallizing optics that the future is now—both from an export and operational perspective.

Outside of a select few Big Cannabis compatriots, no other junior LP is in position to issue that type of salacious presser. It’s the kind of release which shows that Maricann is more carnivore than minnow in the shark tank. The more the market learns of positive developments in Germany—the golden jewel of the cannabis world with 80 million people and strong CDN/EUR exchange rate—the better.

Final Thoughts

Maricann Group could be among the few long-term survivors in Canadian junior cannabis space today (

The private placement was the missing piece to coalesce the entire puzzle into place. It assured the company enough wiggle room to meet its build-out requirements, and bridges Maricann into the post-legalization period when revenues start flooding in. Gradually—and now suddenly—the market is waking up to Maricann’s uniquely positioned value proposition.

Original article: Maricann Group Inc Separating Itself From The Junior Cannabis Pack

©2018 Midas Letter. All Rights Reserved.